Xenon Pharmaceuticals Inc.
XENE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582313
In the last 90 days, Xenon Pharmaceuticals Inc. insiders filed 2 open-market purchases and 2 sales; 315 institutions reported holding it in 13F filings for Q2 2026, worth $6.10B in total; Duquesne Family Office is the only superinvestor holding it.
Q1 2025 vs. Q4 2024
How the institutions holding Xenon Pharmaceuticals Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 209 | 206 | −3 |
| Shares | 76.3M | 76.7M | +410.6K (+0.5%) |
| Value | $2.99B | $2.58B | −$414.7M (−13.9%) |
New holders (20)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Logos Global Management LP | 650,000 | $21.8M | 3.88% |
| Point72 Asset Management, L.P. | 209,759 | $7.04M | 0.02% |
| Mutual of America Capital Management LLC | 48,763 | $1.64M | 0.02% |
| CenterBook Partners LP | 22,211 | $745.2K | 0.05% |
| Y-Intercept (Hong Kong) Ltd | 11,949 | $400.9K | 0.03% |
| Silverarc Capital Management, LLC | 10,121 | $339.6K | 0.07% |
| Legato Capital Management LLC | 9,622 | $322.8K | 0.04% |
| SEI Investments Co | 9,404 | $315.5K | 0.00% |
| EntryPoint Capital, LLC | 8,872 | $297.7K | 0.14% |
| Twinbeech Capital LP | 6,445 | $216.2K | 0.00% |
| Oxford Asset Management LLP | 6,174 | $207.1K | 0.09% |
| Virtus Investment Advisers, Inc. | 4,161 | $139.6K | 0.04% |
| Caitong International Asset Management Co., Ltd | 905 | $30.4K | 0.02% |
| Coldstream Capital Management Inc | 648 | $21.7K | 0.00% |
| Point72 Hong Kong Ltd | 329 | $11.0K | 0.00% |
| Point72 (DIFC) Ltd | 66 | $2.21K | 0.00% |
| Massmutual Trust Co FSB | 39 | $1.31K | 0.00% |
| CIBC Private Wealth Group, LLC | 39 | $1.10K | 0.00% |
| Park Place Capital Corp | 16 | $537 | 0.00% |
| True Wealth Design, LLC | 9 | $302 | 0.00% |
Sold out (23)
Institutions that held Xenon Pharmaceuticals Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Walleye Capital LLC | 221,982 | $8.70M |
| Eversept Partners, LP | 155,540 | $6.10M |
| Ikarian Capital, LLC | 62,052 | $2.43M |
| LMR Partners LLP | 48,668 | $1.91M |
| Woodline Partners LP | 39,938 | $1.57M |
| Thrivent Financial for Lutherans | 30,699 | $1.20M |
| TD Asset Management Inc | 20,430 | $800.9K |
| Brevan Howard Capital Management LP | 19,005 | $745.0K |
| Boothbay Fund Management, LLC | 17,395 | $681.9K |
| Trexquant Investment LP | 11,397 | $446.8K |
| Jane Street Group, LLC | 11,138 | $436.6K |
| Tudor Investment Corp Et Al | 8,671 | $339.9K |
| Bellevue Group AG | 8,200 | $321.4K |
| XTX Topco Ltd | 8,054 | $315.7K |
| HRT Financial LP | 7,171 | $281.0K |
| Squarepoint Ops LLC | 6,554 | $256.9K |
| Magnetar Financial LLC | 5,363 | $210.2K |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 2,569 | $100.7K |
| Proequities, Inc. | 2,000 | $78.4K |
| Virtus ETF Advisers LLC | 1,802 | $70.6K |
| Quadrant Capital Group LLC | 66 | $2.59K |
| C M Bidwell & Associates Ltd | 9 | $353 |
| Hexagon Capital Partners LLC | 6 | $235 |